fluoxetine has been researched along with Neonatal Abstinence Syndrome in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Her mother had been taking fluoxetine (20 mg daily) during the second and third trimesters of her pregnancy." | 3.74 | Prolonged neonatal complications after in utero exposure to fluoxetine. ( Alehan, F; Gürakan, B; Saygi, S; Tarcan, A, 2008) |
| " Her mother was on 20 mg of fluoxetine throughout her pregnancy." | 3.73 | Fluoxetine withdrawal syndrome in the newborn. ( Anbu, AT; Theodore, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alehan, F | 1 |
| Saygi, S | 1 |
| Tarcan, A | 1 |
| Gürakan, B | 1 |
| Rampono, J | 1 |
| Proud, S | 1 |
| Hackett, LP | 1 |
| Kristensen, JH | 1 |
| Ilett, KF | 1 |
| Anbu, AT | 1 |
| Theodore, A | 1 |
1 trial available for fluoxetine and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Apgar Score; Female; Fetal B | 2004 |
3 other studies available for fluoxetine and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Prolonged neonatal complications after in utero exposure to fluoxetine.
Topics: Adult; Diagnosis, Differential; Female; Fluoxetine; Humans; Infant, Newborn; Neonatal Abstinence Syn | 2008 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; F | 2004 |
Fluoxetine withdrawal syndrome in the newborn.
Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans; Infant, Newborn; Neonatal Abstin | 2006 |